Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice-Reference-Cited by-同舟云学术

Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice

Published:2016-06-23 Issue:8 Volume:5 Page:1897-1907
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Peterson Douglas E.¹,O'Shaughnessy Joyce A.²,Rugo Hope S.³,Elad Sharon⁴⁵,Schubert Mark M.⁶,Viet Chi T.⁷,Campbell‐Baird Cynthia⁸,Hronek Jan⁹,Seery Virginia¹⁰,Divers Josephine²,Glaspy John¹¹,Schmidt Brian L.⁷,Meiller Timothy F.¹²

Affiliation:

1. School of Dental Medicine and Neag Comprehensive Cancer Center UConn Health Farmington Connecticut

2. Texas Oncology‐Baylor Charles A. Sammons Cancer Center Dallas Texas

3. UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California

4. Eastman Institute for Oral Health, University of Rochester Medical Center Rochester New York

5. Wilmot Cancer Center, University of Rochester Medical Center Rochester New York

6. School of Dentistry, University of Washington and Seattle Cancer Care Alliance Seattle Washington

7. New York University College of Dentistry New York New York

8. Penn State Hershey Medical Center Hershey Pennsylvania

9. Tennessee Oncology/Sarah Cannon Research Institute Nashville Tennessee

10. Beth Israel Deaconess Medical Center Boston Massachusetts

11. Jonsson Comprehensive Cancer Center, UCLA Los Angeles California

12. School of Dentistry and the Marlene and Stewart Greenebaum Cancer Center University of Maryland Baltimore Maryland

Funder

Novartis Pharmaceuticals Corporation

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.761

Reference62 articles.

1. Oral mucositis

2. Oral complications of cancer and cancer therapy

3. Management of cancer therapy-induced oral mucositis

4. Incidence and risk factors of oral mucositis in paediatric and adolescent patients undergoing chemotherapy

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of rapamycin on healthspan metrics after one year: PEARL Trial Results;2024-08-22

2. Comparing the risk of severe oral mucositis associated with methotrexate as graft-versus host-disease prophylaxis to other immunosuppressive prophylactic agents in hematopoietic cell transplantation: a systematic review and meta-analysis;Supportive Care in Cancer;2024-07-17

3. Fact-Finding Survey and Exploration of Preventive Drugs for Antineoplastic Drug-Induced Oral Mucositis Using the Japanese Adverse Drug Event Report Database;Scientia Pharmaceutica;2024-06-20

4. Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents;Expert Opinion on Pharmacotherapy;2024-04-12

5. Prevalence and clinical characteristics of oral lesions in heart transplant patients induced by sirolimus and everolimus: a systematic review and meta-analysis on a global scale;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2024-01